136 related articles for article (PubMed ID: 32080901)
1. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice.
El-Sisi AE; Sokar SS; Ibrahim HA; Abu-Risha SE
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1113-1129. PubMed ID: 31950222
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
[TBL] [Abstract][Full Text] [Related]
4. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice.
Zidan A; El Saadany AA; El Maghraby GM; Abdin AA; Hedya SE
Toxicol Appl Pharmacol; 2023 Apr; 465():116448. PubMed ID: 36921847
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling.
Chen S; Ren Y; Duan P
Biomed Pharmacother; 2020 Sep; 129():110371. PubMed ID: 32563984
[TBL] [Abstract][Full Text] [Related]
6. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
Khedr NF; Khalil RM
Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
El-Naa MM; Othman M; Younes S
Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
[TBL] [Abstract][Full Text] [Related]
9. Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity.
Marslin G; Revina AM; Khandelwal VK; Balakumar K; Prakash J; Franklin G; Sheeba CJ
Int J Nanomedicine; 2015; 10():3163-70. PubMed ID: 25995626
[TBL] [Abstract][Full Text] [Related]
10. The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response.
Aboalsoud A; El-Ghaiesh SH; Abd Elmonem FF; Salem ML; Abdel Rahman MN
Int Immunopharmacol; 2020 Jan; 78():106068. PubMed ID: 31835085
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma.
Kubatka P; Uramova S; Kello M; Kajo K; Kruzliak P; Mojzis J; Vybohova D; Adamkov M; Jasek K; Lasabova Z; Zubor P; Fialova S; Dokupilova S; Solar P; Pec M; Adamicova K; Danko J; Adamek M; Busselberg D
J Cell Mol Med; 2017 Nov; 21(11):2837-2851. PubMed ID: 28524540
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an
Negi LM; Talegaonkar S; Jaggi M; Verma AK
J Drug Target; 2019 Feb; 27(2):183-192. PubMed ID: 29972336
[TBL] [Abstract][Full Text] [Related]
13. Trichinella spiralis Larval Extract as a Biological Anti-Tumor Therapy in a Murine Model of Ehrlich Solid Carcinoma.
Younis SS; Salama AM; Elmehy DA; Heabah NA; Rabah HM; Elakshar SH; Awad RA; Gamea GA
Parasite Immunol; 2024 May; 46(5):e13035. PubMed ID: 38712475
[TBL] [Abstract][Full Text] [Related]
14. Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells.
Sadat Shandiz SA; Shafiee Ardestani M; Shahbazzadeh D; Assadi A; Ahangari Cohan R; Asgary V; Salehi S
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-10. PubMed ID: 27362495
[TBL] [Abstract][Full Text] [Related]
15. Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice.
Donia TIK; Gerges MN; Mohamed TM
Chem Biol Interact; 2018 Apr; 285():76-84. PubMed ID: 29481770
[TBL] [Abstract][Full Text] [Related]
16. Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.
Ali SA; Zaitone SA; Moustafa YM
Can J Physiol Pharmacol; 2015 Aug; 93(8):695-708. PubMed ID: 26230640
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity.
Ali SH; Sulaiman GM; Al-Halbosiy MMF; Jabir MS; Hameed AH
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):378-394. PubMed ID: 30691314
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice.
Haggag YA; Osman MA; El-Gizawy SA; Goda AE; Shamloula MM; Faheem AM; McCarron PA
Biomed Pharmacother; 2018 Sep; 105():215-224. PubMed ID: 29857301
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
[TBL] [Abstract][Full Text] [Related]
20. Response of MCF-7 Breast Cancer Cells Overexpressed with P-Glycoprotein to Apoptotic Induction after Photodynamic Therapy.
Aniogo EC; George BP; Abrahamse H
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
